Atos, Roselyn M.

HRN: 25-36-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2025
CEFTRIAXONE 1G (VIAL)
02/02/2025
02/09/2025
IV
2g
OD
For MRM
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: